New Insights into the Link between Melanoma and Thyroid Cancer: Role of Nucleocytoplasmic Trafficking
Mourad Zerfaoui(Emory University), Emad Kandil(Tulane University)
Cited by 19
Related Papers
Bortezomib sensitizes thyroid cancer to BRAF inhibitor in vitro and in vivo
|Endocrine Related Cancer|2017|28
A Predictive Model of Adaptive Resistance to BRAF/MEK Inhibitors in Melanoma
|International Journal of Molecular Sciences|2023|6